LIVE
BREAKING
COP31 Draft Cover Decision Drops Fossil Fuels as Slimmed-Down Text Lands in AntalyaCOP31 Draft Deal Welcomes Antalya Compact to Cut Building Energy Use by 25% by 2035COP31 Puts Homes at the Centre — but Will the Money Follow?UK Seeks Wider Defence Cooperation with Türkiye Beyond Eurofighter DealTrump, Xi and Putin Issue ‘Peace Declaration’ After First-Ever Trilateral Summit in ShenzhenTrump Says US Will ‘See What Happens’ on Iran After January 1COP31: TeraMed Launches Mediterranean Renewable Energy Finance Hub, Targeting $20 Billion by 2028World Marathon Champion Peres Jepchirchir Banned for Three Years Over EPO UseTusk: ‘God, Protect Us From Such Friends’ After Trump Greets PutinICJ Rules Myanmar Committed Genocide Against Rohingya in 2017 CrackdownCOP31 Backs Global Action on Extreme Heat and Sustainable CoolingWorld Court Finds Myanmar Forces Killed Around 10,000 Rohingya in 2017 CrackdownICESCO Launches Youth Climate Leaders Initiative at COP31 in AntalyaPakistan and ASEAN Pledge Deeper Trade and Economic CooperationFrance Raises Bird Flu Alert to Maximum as Seasonal Wave SpreadsBangladesh Lockdown Turns Violent as Yunus Ancestral Home Is TorchedD-8 Ministers Adopt Antalya Climate Framework at COP31 as Champion Ağırbaş Pushes Zero WasteRussian Bombers Fly Near Taiwan Again in Second Incident This WeekDenmark Set to Ratify Greenland Security Deal with the US TodayCOP31: Stiell Calls Electrification a ‘Lightbulb Moment’ as Delivery Package LaunchesCOP31 Draft Cover Decision Drops Fossil Fuels as Slimmed-Down Text Lands in AntalyaCOP31 Draft Deal Welcomes Antalya Compact to Cut Building Energy Use by 25% by 2035COP31 Puts Homes at the Centre — but Will the Money Follow?UK Seeks Wider Defence Cooperation with Türkiye Beyond Eurofighter DealTrump, Xi and Putin Issue ‘Peace Declaration’ After First-Ever Trilateral Summit in ShenzhenTrump Says US Will ‘See What Happens’ on Iran After January 1COP31: TeraMed Launches Mediterranean Renewable Energy Finance Hub, Targeting $20 Billion by 2028World Marathon Champion Peres Jepchirchir Banned for Three Years Over EPO UseTusk: ‘God, Protect Us From Such Friends’ After Trump Greets PutinICJ Rules Myanmar Committed Genocide Against Rohingya in 2017 CrackdownCOP31 Backs Global Action on Extreme Heat and Sustainable CoolingWorld Court Finds Myanmar Forces Killed Around 10,000 Rohingya in 2017 CrackdownICESCO Launches Youth Climate Leaders Initiative at COP31 in AntalyaPakistan and ASEAN Pledge Deeper Trade and Economic CooperationFrance Raises Bird Flu Alert to Maximum as Seasonal Wave SpreadsBangladesh Lockdown Turns Violent as Yunus Ancestral Home Is TorchedD-8 Ministers Adopt Antalya Climate Framework at COP31 as Champion Ağırbaş Pushes Zero WasteRussian Bombers Fly Near Taiwan Again in Second Incident This WeekDenmark Set to Ratify Greenland Security Deal with the US TodayCOP31: Stiell Calls Electrification a ‘Lightbulb Moment’ as Delivery Package Launches
CEOs

Danaher Names Julie Sawyer Montgomery as New CEO Ahead of October Earnings Test

News Desk 6Published October 5, 2026
Danaher Names Julie Sawyer Montgomery as New CEO Ahead of October Earnings Test
Share this story

Danaher Corporation has completed a planned executive succession, installing Julie Sawyer Montgomery as president and chief executive officer effective October 1, 2026. The handover places the new Danaher CEO in charge just weeks before the life sciences group reports its third-quarter 2026 results, putting her straight into the spotlight with investors.

Danaher CEO Julie Sawyer Montgomery takes over as scientists work in a diagnostics laboratory
Danaher built its Diagnostics platform into a market-leading business under Montgomery’s leadership before promoting her to chief executive.

What the New Danaher CEO Inherits

Sawyer Montgomery joined Danaher in 2017 and played a central role in transforming the company’s Diagnostics platform into a market-leading franchise. Under her stewardship, the business grew from roughly 6 billion dollars in revenue in 2017 to about 11 billion dollars today, while approximately tripling operating profit, according to the company’s announcement.

That track record matters because Danaher is navigating a cyclical turn in life sciences demand. In its second-quarter report, the company projected full-year 2026 core revenue growth of 3 to 4 percent, after biopharmaceutical customers deferred delivery of roughly 100 million dollars in bioprocessing equipment and resin shipments into 2027.

Succession Plan Executed on Schedule

The change was not a surprise to the market. Danaher first communicated the executive succession plan on August 3, 2026, and the board’s formal appointment took effect on October 1 exactly as scheduled.

Former president and chief executive Rainer Blair stepped down from his executive duties but will remain with the company as a senior advisor through March 31, 2027, to ensure a seamless transition, the company said.

Chairman Steven Rales backed the appointment, saying Sawyer Montgomery has “the vision, experience, and proven track record to deliver” on the company’s growth potential, citing her commitment to innovation, commercial excellence and operational rigor.

Earnings Test Set for October 21

Danaher has scheduled its third-quarter 2026 earnings conference call for October 21, 2026. The update will give investors the first detailed read on performance under the new chief executive, covering demand in biotechnology, diagnostics and life sciences.

Analysts remain broadly constructive. Guggenheim raised its Danaher price target from 200 to 250 dollars on October 1, keeping a Buy rating, while MarketBeat lists a Strong Buy consensus across 25 analysts with an average 12-month price target near 232 dollars.

Shares fell on the transition day, closing at 211.71 dollars on October 1, down 4.5 percent, as investors weighed near-term execution risk during the management change against the company’s longer-term growth story.

FAKTA

  • Julie Sawyer Montgomery became president and CEO of Danaher on October 1, 2026, and joined the board of directors.
  • Former CEO Rainer Blair retired from executive duties and will serve as senior advisor through March 31, 2027.
  • Under Montgomery, the Diagnostics platform grew from about 6 billion to about 11 billion dollars in revenue since 2017.
  • Danaher reports third-quarter 2026 results on October 21, 2026.
  • The company guides full-year 2026 core revenue growth of 3 to 4 percent.

Conclusion

Danaher’s succession gives the life sciences group a diagnostics-proven insider at a moment when demand recovery matters more than promises. Whether the new Danaher CEO can convert the diagnostics playbook into enterprise-wide growth will be tested as early as October 21, when third-quarter numbers land.

For more coverage of global business leadership and corporate transitions, visit the Watan News International English edition.

Frequently Asked Questions

Related Stories

Planet & environment

Climate & Sustainability

News, stories and solutions driving change towards a greener and more sustainable planet for future generations.

COP31 Draft Cover Decision Drops Fossil Fuels as Slimmed-Down Text Lands in Antalya
Featured story

COP31 Draft Cover Decision Drops Fossil Fuels as Slimmed-Down Text Lands in Antalya

COP31 negotiators published a slimmed-down draft cover decision in Antalya on Thursday — 80 paragraphs, down from 144 — with no mention of fossil fuels. Finance and electrification stay at the centre as talks enter their final day.

Read full story

GREEN JOURNALISM

Every Action Counts

Small steps today, big impact tomorrow.

Explore more stories